Second TRICALS Masterclass postponed

As a result of the continuing global uncertainty caused by the COVID-19 pandemic, TRICALS has taken the difficult decision to postpone the TRICALS Masterclass 2020 until further notice. We are now working find a suitable date for this event in 2021. More details will be announced on our website through our newsletter


Share

Related news

CENTAUR phase 2 trial reveals promising results
CENTAUR phase 2 trial reveals promising results
New findings from the CENTAUR trial show that the drug ‘sodium phenylbutyrate–taurursodiol’ […]
Current developments in clinical trial design and conduct
Current developments in clinical trial design and conduct
Over 70 compounds have been evaluated by clinical studies, yet Riluzole is […]
Reforming clinical studies for ALS
Reforming clinical studies for ALS
In order to find new treatments for ALS, our current strategy for […]
The European Medicines Agency (EMA) endorses TRICALS' innovative platform trial
The European Medicines Agency (EMA) endorses TRICALS' innovative platform trial
TRICALS has received the exciting news that the European Medicines Agency (EMA) […]